- Supported exchanges /
- F /
- 9PL.F
GENINCODE PLC LS -01 (9PL F) stock market data APIs
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis. In addition, the company offers Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.
GENINCODE PLC LS -01 Financial Data Overview
0.0445 | |
0.0475 | |
- | |
0.0475 | |
0.0445 | |
0.0385-0.107 | |
8 832 K | |
177 M | |
2 599 K | |
0.663 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
GENINCODE PLC LS -01 Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 599 K
- EBITDA -5 767 000
- Earnings Per Share -0.06
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get GENINCODE PLC LS -01 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get GENINCODE PLC LS -01 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: